• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Consumer Cyclical·000516.SZ
Share

Xi'an International Medical Investment Company Limited Stocks

CN¥ 4.11Last Updated 13.07.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.35B

CN¥ 4.11
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Xi'an International Medical Investment Company Limited, an organization headquartered in Xi'an, China, specializes in delivering a comprehensive range of medical services. The company achieves this through the management and operation of its various hospitals and medical centers. Established in 1956, the firm underwent a name change in January 2015, transitioning from its former designation, Xi'an Kaiyuan Investment Group Co., Ltd., to its present identity.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA, undervalued on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 000516.SZ is 5.70 and suggests 39% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.07.2026 20:30

Shares of a small software developer soared following news of its possible sale

13.07.2026 19:53

Trump announced the resumption of the blockade of the Strait of Hormuz against Iranian vessels

13.07.2026 19:20

Volkswagen has announced plans to lay off another 50,000 employees to cut costs

13.07.2026 18:52

Kazakhstani banks topped The Banker's rankings for profitability and capital growth in Asia

13.07.2026 18:41

Chipmakers' sell-off and a new escalation in Iran: How the market opened

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026